Author Search Results :: UTM Library Massive Scholar Tracking

1

Evolution of systemic treatment for hormone-sensitive breast cancer: from sequential use of single agents to the upfront administration of drug combinations by E. N. Imyanitov

Published 2016-09-01

Get full text

Article

2

CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB – A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER by E. N. Imyanitov, T. Yu. Semiglazova

Published 2017-12-01

Get full text

Article

3

Molecular pathology of lung cancer: clinical aspects by I. S. Polyakov, E. N. Imyanitov

Published 2016-02-01

Get full text

Article

4

Molecular-based choice of cytotoxic therapy for cancer by E. N. Imyanitov, V. M. Moiseyenko

Published 2022-11-01

Get full text

Article

5

The role of molecular diagnostics in the choice of therapy for biliary tract cancers by N. V. Mitiushkina, E. N. Imyanitov

Published 2024-03-01

Get full text

Article

6

CLINICAL SIGNIFICANCE OF STUDYING GENETIC POLYMORPHISM OF THE Р450 CYP2C9 AND CYP2C19 DETOXIFYING ENZYME GENES IN EPILEPTIC CHILDREN by O. V. Guzeva, E. N. Imyanitov

Published 2016-05-01

Get full text

Article

7

Immune checkpoint inhibitors for the treatment of solid tumors in HIV-infected patients: is it worth the risk? by E. A. Degtiareva, S. A. Protsenko, E. N. Imyanitov

Published 2023-02-01

Get full text

Article

8

MOLECULAR-GENETIC «PORTRAIT» OF BREAST CANCER by S. A. Laptiev, M. A. Korzhenevskaia, E. N. Imyanitov

Published 2017-06-01

Get full text

Article

9

Clinical features of BRCA-positive ovarian cancer by S. Ya. Maximov, E. N. Imyanitov, K. D. Guseinov, T. V. Gorodnova

Published 2016-02-01

Get full text

Article

10

GENETICS OF SUSCEPTIBILITY TO INFECTIOUS DISEASES by E. N. Suspitsin, E. Yu. Skripchenko, E. N. Imyanitov, N. V. Skripchenko

Published 2017-04-01

Get full text

Article

11

Pharmacogenomics in pediatric oncology: possibility to overcome drug-induced toxicity of anticancer treatment by Yu. V. Dinikina, E. N. Imyanitov, M. B. Belogurova, I. L. Nikitina

Published 2024-01-01

Get full text

Article

12

MEDICAL AND GENETIC COUNSELING OF HEREDITARY BREAST AND OVARIAN CANCER by S. A. Laptiev, M. A. Korzhenevskaia, A. P. Sokolenko, A. G. Iyevleva, E. N. Imyanitov

Published 2018-06-01

Get full text

Article

13

Features and complexity of treatment of BRCA-associated ovarian cancer, chronic disease: literature review by T. V. Gorodnova, A. P. Sokolenko, Kh. B. Kotiv, I. V. Berlev, E. N. Imyanitov

Published 2024-11-01

Get full text

Article

14

Hereditary ovarian cancer by Kh. B. Kotiv, T. V. Gorodnova, A. P. Sokolenko, I. V. Berlev, E. N. Imyanitov

Published 2022-11-01

Get full text

Article

15

MOLECULAR MARKERS OF SENSITIVITY AND RESISTANCE OF COLORECTAL CANCER TO ANTI-EGFR T by A. O. Ivantsov, G. A. Yanus, E. N. Suspitsin, E. I. Anisimova, E. N. Imyanitov

Published 2016-04-01

Get full text

Article

16

HRD-negative high-grade carcinoma of the ovary in BRCA2 pathogenic variant carrier by A. P. Sokolenko, S. V. Poletaeva, A. D. Shestakova, T. V. Gorodnova, I. V. Berlev, E. N. Imyanitov

Published 2024-05-01

Get full text

Article

17

EXPRESSION OF TH17-LYMPHOCYTE ADAPTER – TRAF3IP2 IN THE SKIN OF PSORIASIS PATIENTS by V. R. Khairutdinov, A. F. Mikhailichenko, A. A. Piskunova, N. V. Bychkova, A. V. Samtsov, E. N. Imyanitov

Published 2014-07-01

Get full text

Article

18

Tumor immune microenvironment and apoptotic markers in breast cancer patients carrying BRCA1 gene mutations by A. I. Stukan, A. Yu. Goryainova, O. Yu. Chukhray, S. D. Maksimenko, E. N. Imyanitov, S. V. Sharov, Z. K. Khachmamuk

Published 2022-09-01

Get full text

Article

19

Modern combined targeted and immunotherapy of metastatic skin melanoma by S. A. Protsenko, E. N. Imyanitov, A. I. Semenova, D. Kh. Latipova, A. V. Novik, D. O. Yurlov, A. P. Oganesian

Published 2020-12-01

Get full text

Article

20

Reactivaion of immune-related colitis during targeted therapy in a patient with metastatic cutaneous melanoma by E. A. Degtiareva, S. A. Protsenko, E. N. Imyanitov, G. M. Teletaeva, D. Kh. Latipova, A. I. Semenova, A. V. Novik

Published 2022-11-01

Get full text

Article

Evolution of systemic treatment for hormone-sensitive breast cancer: from sequential use of single agents to the upfront administration of drug combinations by E. N. Imyanitov

CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB – A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER by E. N. Imyanitov, T. Yu. Semiglazova

Molecular pathology of lung cancer: clinical aspects by I. S. Polyakov, E. N. Imyanitov

Molecular-based choice of cytotoxic therapy for cancer by E. N. Imyanitov, V. M. Moiseyenko

The role of molecular diagnostics in the choice of therapy for biliary tract cancers by N. V. Mitiushkina, E. N. Imyanitov

CLINICAL SIGNIFICANCE OF STUDYING GENETIC POLYMORPHISM OF THE Р450 CYP2C9 AND CYP2C19 DETOXIFYING ENZYME GENES IN EPILEPTIC CHILDREN by O. V. Guzeva, E. N. Imyanitov

Immune checkpoint inhibitors for the treatment of solid tumors in HIV-infected patients: is it worth the risk? by E. A. Degtiareva, S. A. Protsenko, E. N. Imyanitov

MOLECULAR-GENETIC «PORTRAIT» OF BREAST CANCER by S. A. Laptiev, M. A. Korzhenevskaia, E. N. Imyanitov

Clinical features of BRCA-positive ovarian cancer by S. Ya. Maximov, E. N. Imyanitov, K. D. Guseinov, T. V. Gorodnova

GENETICS OF SUSCEPTIBILITY TO INFECTIOUS DISEASES by E. N. Suspitsin, E. Yu. Skripchenko, E. N. Imyanitov, N. V. Skripchenko

Pharmacogenomics in pediatric oncology: possibility to overcome drug-induced toxicity of anticancer treatment by Yu. V. Dinikina, E. N. Imyanitov, M. B. Belogurova, I. L. Nikitina

MEDICAL AND GENETIC COUNSELING OF HEREDITARY BREAST AND OVARIAN CANCER by S. A. Laptiev, M. A. Korzhenevskaia, A. P. Sokolenko, A. G. Iyevleva, E. N. Imyanitov

Features and complexity of treatment of <i>BRCA</i>-associated ovarian cancer, chronic disease: literature review by T. V. Gorodnova, A. P. Sokolenko, Kh. B. Kotiv, I. V. Berlev, E. N. Imyanitov

Hereditary ovarian cancer by Kh. B. Kotiv, T. V. Gorodnova, A. P. Sokolenko, I. V. Berlev, E. N. Imyanitov

MOLECULAR MARKERS OF SENSITIVITY AND RESISTANCE OF COLORECTAL CANCER TO ANTI-EGFR T by A. O. Ivantsov, G. A. Yanus, E. N. Suspitsin, E. I. Anisimova, E. N. Imyanitov

HRD-negative high-grade carcinoma of the ovary in <i>BRCA2</i> pathogenic variant carrier by A. P. Sokolenko, S. V. Poletaeva, A. D. Shestakova, T. V. Gorodnova, I. V. Berlev, E. N. Imyanitov

EXPRESSION OF TH17-LYMPHOCYTE ADAPTER – TRAF3IP2 IN THE SKIN OF PSORIASIS PATIENTS by V. R. Khairutdinov, A. F. Mikhailichenko, A. A. Piskunova, N. V. Bychkova, A. V. Samtsov, E. N. Imyanitov

Tumor immune microenvironment and apoptotic markers in breast cancer patients carrying <I>BRCA1</I> gene mutations by A. I. Stukan, A. Yu. Goryainova, O. Yu. Chukhray, S. D. Maksimenko, E. N. Imyanitov, S. V. Sharov, Z. K. Khachmamuk

Modern combined targeted and immunotherapy of metastatic skin melanoma by S. A. Protsenko, E. N. Imyanitov, A. I. Semenova, D. Kh. Latipova, A. V. Novik, D. O. Yurlov, A. P. Oganesian

Reactivaion of immune-related colitis during targeted therapy in a patient with metastatic cutaneous melanoma by E. A. Degtiareva, S. A. Protsenko, E. N. Imyanitov, G. M. Teletaeva, D. Kh. Latipova, A. I. Semenova, A. V. Novik

Evolution of systemic treatment for hormone-sensitive breast cancer: from sequential use of single agents to the upfront administration of drug combinations by E. N. Imyanitov

CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB – A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER by E. N. Imyanitov, T. Yu. Semiglazova

Molecular pathology of lung cancer: clinical aspects by I. S. Polyakov, E. N. Imyanitov

Molecular-based choice of cytotoxic therapy for cancer by E. N. Imyanitov, V. M. Moiseyenko

The role of molecular diagnostics in the choice of therapy for biliary tract cancers by N. V. Mitiushkina, E. N. Imyanitov

CLINICAL SIGNIFICANCE OF STUDYING GENETIC POLYMORPHISM OF THE Р450 CYP2C9 AND CYP2C19 DETOXIFYING ENZYME GENES IN EPILEPTIC CHILDREN by O. V. Guzeva, E. N. Imyanitov

Immune checkpoint inhibitors for the treatment of solid tumors in HIV-infected patients: is it worth the risk? by E. A. Degtiareva, S. A. Protsenko, E. N. Imyanitov

MOLECULAR-GENETIC «PORTRAIT» OF BREAST CANCER by S. A. Laptiev, M. A. Korzhenevskaia, E. N. Imyanitov

Clinical features of BRCA-positive ovarian cancer by S. Ya. Maximov, E. N. Imyanitov, K. D. Guseinov, T. V. Gorodnova

GENETICS OF SUSCEPTIBILITY TO INFECTIOUS DISEASES by E. N. Suspitsin, E. Yu. Skripchenko, E. N. Imyanitov, N. V. Skripchenko

Pharmacogenomics in pediatric oncology: possibility to overcome drug-induced toxicity of anticancer treatment by Yu. V. Dinikina, E. N. Imyanitov, M. B. Belogurova, I. L. Nikitina

MEDICAL AND GENETIC COUNSELING OF HEREDITARY BREAST AND OVARIAN CANCER by S. A. Laptiev, M. A. Korzhenevskaia, A. P. Sokolenko, A. G. Iyevleva, E. N. Imyanitov

Features and complexity of treatment of <i>BRCA</i>-associated ovarian cancer, chronic disease: literature review by T. V. Gorodnova, A. P. Sokolenko, Kh. B. Kotiv, I. V. Berlev, E. N. Imyanitov

Hereditary ovarian cancer by Kh. B. Kotiv, T. V. Gorodnova, A. P. Sokolenko, I. V. Berlev, E. N. Imyanitov

MOLECULAR MARKERS OF SENSITIVITY AND RESISTANCE OF COLORECTAL CANCER TO ANTI-EGFR T by A. O. Ivantsov, G. A. Yanus, E. N. Suspitsin, E. I. Anisimova, E. N. Imyanitov

HRD-negative high-grade carcinoma of the ovary in <i>BRCA2</i> pathogenic variant carrier by A. P. Sokolenko, S. V. Poletaeva, A. D. Shestakova, T. V. Gorodnova, I. V. Berlev, E. N. Imyanitov

EXPRESSION OF TH17-LYMPHOCYTE ADAPTER – TRAF3IP2 IN THE SKIN OF PSORIASIS PATIENTS by V. R. Khairutdinov, A. F. Mikhailichenko, A. A. Piskunova, N. V. Bychkova, A. V. Samtsov, E. N. Imyanitov

Tumor immune microenvironment and apoptotic markers in breast cancer patients carrying <I>BRCA1</I> gene mutations by A. I. Stukan, A. Yu. Goryainova, O. Yu. Chukhray, S. D. Maksimenko, E. N. Imyanitov, S. V. Sharov, Z. K. Khachmamuk

Modern combined targeted and immunotherapy of metastatic skin melanoma by S. A. Protsenko, E. N. Imyanitov, A. I. Semenova, D. Kh. Latipova, A. V. Novik, D. O. Yurlov, A. P. Oganesian

Reactivaion of immune-related colitis during targeted therapy in a patient with metastatic cutaneous melanoma by E. A. Degtiareva, S. A. Protsenko, E. N. Imyanitov, G. M. Teletaeva, D. Kh. Latipova, A. I. Semenova, A. V. Novik

Search Tools: